CTHRC1 overexpression induced ovarian cancer cell lines to undergo EMT and promoted cell migration and invasion through activating Wnt/β-catenin signaling, making CTHRC1 a potential target for EOC treatment. The gene discussed is CTHRC1; the disease is ovarian cancer.